Meridian Bioscience reported $70.1M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Becton, Dickinson and BDX:US $ 3163M 95M
Bio Rad Laboratories BIO:US $ 657.13M 51.64M
Cerus CERS:US $ 27.76M 0.76M
Meridian Bioscience VIVO:US $ 70.1M 0.82M
Myriad Genetics MYGN:US $ 15.4M 0.2M
Orasure Technologies OSUR:US $ 71.3M 9.77M
Quidel QDEL:US $ 552.7M 371.31M
Staar Surgical STAA:US $ 18.09M 0.36M
Thermo Fisher Scientific TMO:US $ 5668M 185M